15 June 2020
https://academic.oup.com/ndt/article/doi/10.1093/ndt/gfaa084/5857810
Midkine and chronic kidney disease–associated multisystem organ dysfunctions
This review summarizes the growing body of evidence supporting MK’s potential role in driving CKD-related multisystem disease, including MK’s relationship with the endothelial glycocalyx, the deranged MK levels and glycocalyx profile in CKD patients and a proposed model of MK organ interplay in CKD disease processes and highlights the importance of ongoing research into MK’s potential as a therapeutic target.
Victoria K Campbell, Ryan P Gately, Rathika Krishnasamy, Dominic Burg, Graham R Robertson, Nicholas A Gray
- Forums
- ASX - By Stock
- AN1
- Midkine News 2020
Midkine News 2020, page-31
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $119 | 17.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 197856 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 280000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 197856 | 0.007 |
4 | 2016527 | 0.006 |
2 | 489026 | 0.005 |
2 | 525000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
0.022 | 4000 | 1 |
Last trade - 11.44am 30/07/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online